May 16, 2008
Home
About
Submit Press Release
PR Firms
Editors/Journalists
Search Archives
 
News Releases by Category  
News by Country  
News by MSA  
All News for Today  
Browse News by Day  
News by Trackbacks  
All Press Releases for March 24, 2008 Subscribe to this News Feed  
 

Individuals Who Were Exposed to Trasylol or Hospital Professionals with Information About Drug Companies Paying Physicians a Consulting Fee Should Contact Americas Watchdog Immediately

Download this press release as an Adobe PDF document.

Americas Watchdog is conducting a national investigation of the heart medication called Trasylol. Individuals who came into contact with this heart medication could be at severe risk or may have already been injured. The group is also seeking hospital employees or medical staff members who might have information about drug companies paying off physicians with consulting arrangements in order to insure usage of a specific drug.

(PRWEB) March 24, 2008 -- Americas Watchdog is leading a national investigation related to individuals who may have been exposed to the heart medication called Trasylol. According to numerous news accounts the heart medication called Trasylol has been attributed to death or kidney failure on the part of individuals who may have been exposed to this medication. According to the news program 60 Minutes, Trasylol may be responsible for the deaths of 22,000 US citizens. Trasylol was used in up to 1/3rd of all US open heart surgeries until recently. Individuals or family members who have knowledge of Trasylol being used in a open heart surgical procedure should contact Americas Watchdog immediately at 866-714-6466.

News Image

this fact is ridiculous as there effective generics available at less than $10 with no known side affects. If a nurse, doctor, hospital staff member, family member or any one else has specific information about Trasylol, they should call Americas Watchdog immediately at 866-714-6466
Americas Watchdog also seeks to talk to medical professionals or hospital staff members who might have specific information about drug companies giving physicians lucrative "consulting" arrangements provided the physician continues to provide a certain manufactures drug. According to Americas Watchdog, "we consider drug consulting arrangements to be no different than a pay off and our group intends to put a stop to it. We do not care how many members of Congress have been bought off by drug companies, wrong is wrong". Hospital or medical professionals with specific information about drug company/physician consulting arrangements should call Americas Watchdog immediately at 866-714-6466.

In the case of Trasylol, a single dose cost $1000 or more. According to Americas Watchdog, "this fact is ridiculous as there effective generics available at less than $10 with no known side affects. If a nurse, doctor, hospital staff member, family member or any one else has specific information about Trasylol, they should call Americas Watchdog immediately at 866-714-6466".

Americas Watchdog is all about consumer protection and corporate responsibility. Their web site is located at Http://AmericasWatchdog.Com

# # #

Trackback URL: http://www.prweb.com/pingpr.php/U3F1YS1aZXRhLVNpbmctQ291cC1TdW1tLVplcm8=


Email this story to a colleague
Printer Friendly Version
Bookmark with del.icio.us
Bookmark with Y!MyWeb
Submit to Digg
THOMAS MARTIN
Americas Watchdog
866-714-6466
Email us Here

There are no multimedia files attached to this release. If this is your release you may add images or other multimedia files through your login.

If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PR Web™. We will be unable to assist you with your inquiry.
PR Web™ disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2005, PRWeb™. All Rights Reserved

Terms of Service | Privacy Policy